News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC – International Urology Cancer Summit
Arnab Basu/uabmedicine.org
Jan 2, 2025, 19:20

Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC – International Urology Cancer Summit

International Urology Cancer Summit shared an article by Arnab Basu on LinkedIn:

“Advancing Precision Oncology in Metastatic RCC.

New findings highlight the potential of longitudinal ctDNA monitoring as a predictive biomarker for treatment response and progression-free survival in metastatic renal cell carcinoma (RCC).

This study demonstrates high concordance between ctDNA dynamics and clinical outcomes, paving the way for more personalized approaches to therapy and surveillance.

Discover how these insights could impact the future of RCC management.

Read the full study here.”

Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC - International Urology Cancer Summit

Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma.

Authors: Arnab Basu, et al.

 Longitudinal ctDNA monitoring as a predictive biomarker for metastatic RCC - International Urology Cancer Summit

Arnab Basu cancer ctDNA fight against cancer Global fight against cancer International Urology Cancer Summit metastatic renal cell carcinoma mRCC OncoDaily Oncology Precision Oncology
Special Coverage
Blog
Mar 10, 2025, 09:36
Sakditad Saowapa: Great catch and inspiring discussions at JSMO25
Insight
Mar 10, 2025, 09:32
Douglas Flora: Starting the Volume 2 of AI in Precision Oncology
Blog
Mar 10, 2025, 09:27
Roberto Iacovelli has received an Impact Award from European Urology Journal for the Tide-A Phase 2 study
Science
Mar 10, 2025, 09:12
Myeloma Paper of the Day, March 10th, suggested by Robert Orlowski
Blog
Mar 10, 2025, 08:54
Martin Kaiser: Co-occurrence of more than 2 HRCAs is associated with highest unmet need in NDMM and RRMM
Blog
Mar 10, 2025, 08:53
Nina Niu Sanford: 73 Questions with Dr. Bob Timmerman
Blog
Mar 10, 2025, 08:40
The Cancer Survivorship Group of Danish Cancer Institute
Blog
Mar 10, 2025, 08:34
The countdown is on for Women Leaders in Oncology 2025 - Vaniam Group
Blog
Mar 10, 2025, 08:32
Bishal Gyawali: Surrogate endpoints in cancer drug trials
Blog
Mar 10, 2025, 08:25
Prerna Mewawalla: Real-world outcomes of sequential BCMA-directed therapy in Multiple Myeloma
Science
Mar 10, 2025, 08:17
Does minimally invasive pancreatoduodenectomy offer real advantages? - SSO
Blog
Mar 10, 2025, 08:14
Peter Pisters: An inspiring evening at 'A Conversation With a Living Legend' event